Medical Center for clinical research

San Diego, California 92120

0 studies enrolling now · 78 studies all time

What they study most

Actinic Keratosis, Atopic Dermatitis, Atrophic Vaginitis Due to Menopause, Bacterial Vaginosis, Benign Prostatic Hypertrophy, COVID-19, COVID-19 Disease, Cervical Intraepithelial Neoplasia, Chlamydia Infections, Chronic Idiopathic Constipation, Chronic Migraine, Contraception

Studies at this site

• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older — Completed
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
• Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy — Completed
• Project STARFISH - PRJ0002679 — Completed
• Butterfly - Clinical Performance Study — Completed
• Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain — Completed
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) — Stopped early
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
• A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis — Stopped early
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder — Completed
• A Study of LY2951742 in Participants With Migraine — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• Biomarker Study in Participants With Migraine — Completed
• Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine — Completed
• Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection — Stopped early
• Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study — Stopped early
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder — Completed
• Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) — Completed
• Evaluating New Formulation of Therapeutic HSV-2 Vaccine — Completed
• Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity — Completed
• Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine — Completed
• Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study — Completed
• LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study — Completed
• Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays — Stopped early
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira — Completed
• Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women — Completed
• A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp — Completed